Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer

BACKGROUND: Lung cancer is one of the leading causes of deaths from cancer worldwide. Tumor virotherapy using naturally oncolytic Newcastle disease virus (NDV) has been shown to be safe and effective in preclinical studies and clinical trials. Previously, we have reported the NDV D90 strain that was...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Zheng, Zhang, Peiyi, Fu, Fang, Zhang, Xueyun, Liu, Ying, Hu, Lihua, Li, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032357/
https://www.ncbi.nlm.nih.gov/pubmed/24885546
http://dx.doi.org/10.1186/1743-422X-11-84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032357/
https://www.ncbi.nlm.nih.gov/pubmed/24885546
http://dx.doi.org/10.1186/1743-422X-11-84

Ejemplares similares